Clinical prospective study to investigate efficacy of WT1 peptide (PepTivator(R))-pulsed dendritic cell vaccination therapy

Trial Profile

Clinical prospective study to investigate efficacy of WT1 peptide (PepTivator(R))-pulsed dendritic cell vaccination therapy

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Dec 2014

At a glance

  • Drugs WT1 peptide-loaded dendritic cell vaccine (Primary)
  • Indications Cancer; Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Dec 2014 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
    • 09 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 07 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top